Molecular Insight (MIPI) Announces Resignation of Chief Medical Officer
Molecular Insight Pharmaceuticals (NASDAQ: MIPI) announced that Norman D. LaFrance, M.D., has notified the Company of his resignation as Senior Vice President and Chief Medical Officer, effective November 5, 2010.
Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and pioneer in molecular medicine.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and pioneer in molecular medicine.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Fred's, Inc. (FRED) Named Steven R. Fitzpatrick to Board of Directors
- Barclays Maintains an 'Equalweight' on Brookfield Properties (BPO); Corporate Evolution
- YRC Worldwide (YRCW) Appoints Scott Ware as President of Holland Subsidiary
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
